CNSP Stock Summary and Trading Ideas (CNS Pharmaceuticals | NASDAQ:CNSP)

CNS Pharmaceuticals Inc is a biotechnology company focused on developing therapies for serious diseases in neurology and oncology. The company is building a high-value pipeline for neurology and oncology indications. Its new corporate includes pivoting from a singular focus on glioblastoma multiforme and exploring out-licensing opportunities for its legacy assets, TPI 287 and Berubicin.

CNS Pharmaceuticals trades on the NASDAQ stock market under the symbol CNSP.

As of June 4, 2026, CNSP stock price climbed to $5.28 with 20,056 million shares trading.

CNSP has a beta of 3.17, meaning it tends to be more sensitive to market movements. CNSP has a correlation of 0.06 to the broad based SPY ETF.

CNSP has a market cap of $7.72 million. This is considered a Sub-Micro Cap stock.

In the last 3 years, CNSP traded as high as $87,299.99 and as low as $1.90.

CNSP has underperformed the market in the last year with a return of -56.4%, while SPY returned +28.2%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in CNSP shares. However, CNSP has outperformed the market in the last 3 month and 2 week periods, returning +73.7% and +3.5%, while SPY returned +11.5% and +2.1%, respectively. This indicates CNSP has been having a stronger performance recently.

CNSP support price is $4.74 and resistance is $5.74 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that CNSP shares will trade within this expected range on the day.